Clinical Efficacy of Platelet Transfusion
NCT06805097 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 343
Last updated 2025-07-09
Summary
The aim of this study is to analyze the effect of the storage time of platelet concentrates on the occurrence of bleeding events during prophylactic platelet transfusions in patients with hematological malignancies.
Conditions
- Thrombocytopaenia
- Haematological Malignancies
Interventions
- OTHER
-
Self-assessment of bleeding events
After each transfusion, the patient completes a daily bleeding event self-assessment (adapted from the WHO bleeding event scale) until the next transfusion or over a period of 10 days.
Sponsors & Collaborators
-
Centre Hospitalier Universitaire de Besancon
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-06-17
- Primary Completion
- 2028-07-31
- Completion
- 2028-07-31
Countries
- France
Study Locations
More Related Trials
-
Improving Self-Efficacy, Resolving Inflammaging Allo HSCT Survivors in Personal Training
NCT03609203 ·Status: COMPLETED
-
Effect of Indication Based Blood Product Transfusion in Patients Undergoing Major Oncological Surgery
NCT05607940 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Home Blood Transfusions
NCT07121140 ·Status: RECRUITING ·Phase: NA
-
Pilot Study: Patients With Chronic Active Graft Versus Host Disease That Have Failed or Not Tolerated Standard Therapy.
NCT01174277 ·Status: COMPLETED
-
The Use of Intensive Care in Critically Ill Cancer Haematological Patients: "TRIAL-OH"
NCT01172132 ·Status: COMPLETED
-
Supportive Care for Patients With Hematological Malignancies Undergoing Hematopoietic Cell Transplant
NCT01758484 ·Status: COMPLETED ·Phase: NA
-
Precision Medicine for Stem Cell Transplantation
NCT05567289 ·Status: RECRUITING
-
Modified Transplantation Regimen and aGVHD Prophylaxis for Severe Aplastic Anemia in the Setting of Allogeneic HSCT.
NCT06837987 ·Status: COMPLETED
-
Pulmonary Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation
NCT01420172 ·Status: COMPLETED
-
Functional and Phenotypic Characterization of Monocytes in Myeloproliferative Syndromes
NCT06361641 ·Status: RECRUITING ·Phase: NA
-
Pulmonary Complications of Allografts
NCT01219972 ·Status: COMPLETED
-
Effect of Stem Cell Infusion Time on aGVHD in Patients With Nonmalignant Hematologic Diseases
NCT06294691 ·Status: RECRUITING ·Phase: PHASE3
-
Evaluation, Treatment, and Training for Patients With Blood Disorders
NCT00001397 ·Status: COMPLETED
-
Transfusion-Induced Alterations of Pulmonary and Immune Function in Mechanically Ventilated Patients
NCT00751322 ·Status: COMPLETED ·Phase: NA
-
National Marrow Donor Program Long-Term Donor Follow-Up
NCT01362179 ·Status: COMPLETED
-
Clinical and Biomarker Study of the Efficacy of Extracorporeal Photopheresis in Graft-versus-host Disease
NCT03124056 ·Status: COMPLETED
-
Children, Adolescents and Young Adults with Myeloproliferative Neoplasia: Study of Clinico-biological Characteristics and Complications (VYP)
NCT06715267 ·Status: RECRUITING
-
Observational Study Evaluating the Potential Impact of Procalcitonin Testing on Care of Stemcell Transplant Recipients
NCT02035189 ·Status: COMPLETED
-
CHAPTER: Clonal Haematopoiesis Assessment: Prevention, Treatment and Research
NCT07313059 ·Status: RECRUITING
-
Impact of Iron Overload on the Incidence of Liver Complications in Long-Term Survivors (≥10 Years) of Allogeneic Hematopoietic Stem-Cell Transplantation.
NCT07028112 ·Status: RECRUITING
-
A Open Label, Post Marketing Surveillance Study Following Transfusion of INTERCEPT Platelet Components
NCT02549222 ·Status: COMPLETED
-
Impact of Pulmonary Follow-up After Stem Cell Graft
NCT03349372 ·Status: COMPLETED
-
Monoclonal Gammopathy With Clinical Significance in Patients With and Without Haematological Malignancies in Finistère Between 2012 and 2017 (GammaClinik)
NCT06559579 ·Status: COMPLETED
-
Low-Intensity Preparation and Allogeneic Transplant in Patients With Cancers of the Blood
NCT00146055 ·Status: COMPLETED ·Phase: PHASE2
-
Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-versus-host Disease
NCT00504803 ·Status: COMPLETED ·Phase: PHASE2